Viperin is an interferon-inducible protein that is pivotal for eliciting an effective immune response against an array of diverse viral pathogens. Here we describe a mechanism of viperin's broad antiviral activity by demonstrating the protein's ability to synergistically enhance the innate immune dsDNA signalling pathway to limit viral infection. Viperin colocalised with the key signalling molecules of the innate immune dsDNA sensing pathway, STING and TBK1; binding directly to STING and inducing enhanced K63-linked polyubiquitination of TBK1. Subsequent analysis identified viperin's necessity to bind the cytosolic iron-sulphur assembly component 2A, to prolong its enhancement of the type-I interferon response to aberrant dsDNA. Here we show that viperin facilitates the formation of a signalling enhanceosome, to coordinate efficient signal transduction following activation of the dsDNA signalling pathway; which results in an enhanced antiviral state. We also provide evidence for viperin's radical SAM enzymatic activity to self-limit its immunomodulatory functions. This data further defines viperin's role as a positive regulator of innate immune signalling, offering a mechanism of viperin's broad antiviral capacity.
Introduction
Innate immunity constitutes the first line of host defence against viral invasion, acting to both prevent and clear infection, as well as driving a robust adaptive response [1] . A range of germ-line encoded pattern recognition receptors (PRRs) are responsible for detecting various viral structural motifs, termed pathogen associated molecular patterns (PAMPs), upon which a signalling cascade is initiated to elicit an innate immune response [2, 3] . This response is primarily associated with the production of cytokines and chemokines, such as interferon (IFN), which acts in both an autocrine and paracrine manner to induce hundreds of interferon stimulated genes (ISGs) [4] . The products of these ISGs act to both clear the viral infection within the infected cell while simultaneously resisting infection in neighbouring cells (reviewed in [5] ).
The induction of ISGs creates a highly effective antiviral state within a cell, yet the specific antiviral activity has only been characterised for a handful of these genes. Viperin (also known as cig5 and RSAD2) is one of the most well described and potent ISGs, implicated in limiting many viruses from multiple viral families (reviewed in [5, 6] ). Viperin was first identified to have antiviral properties against human cytomegalovirus [5, 7, 8] , and has since been shown to directly target multiple stages of the viral life cycle to inhibit infection of viruses including HCV, DENV, TBEV, HIV, BUNV, ZIKV and IAV (reviewed in [7, 9] ). Viperin has been shown to target the budding of IAV, HIV-1 and RABV, by directly disrupting cellular lipid rafts through interactions likely involving the host protein FPPS [10] [11] [12] . Additionally, the replication of viruses such as HCV and DENV is also a target for viperin's antiviral activity, whereby viperin has been demonstrated to associate with the viral non-structural proteins NS5A and NS3 respectively at the replication complexes of each virus to inhibit infection [13, 14] . However, there is not one direct means of viperin inhibition described for these multiple viral families, which all employ different routes of infection and mechanisms of replication (reviewed in [7, 15] ). As such, viperin has been implicated in interactions with many functionally unrelated host and viral proteins, making it increasingly difficult to identify a unifying mechanism of viperin's antiviral activity.
Viperin is a member of the radical SAM enzyme superfamily [16] [17] [18] [19] . Recent work has demonstrated that mammalian viperin catalyses the dehydration of CTP to form 3',4'didehydro-4'-deoxy-CTP (ddhCTP) through a radical mechanism involving the reductive cleavage of SAM with concomitant formation of 5'-deoxyadenosine (5'-dA) [20] . Like all radical SAM enzymes, viperin relies for activity ,on the insertion of a [4Fe-4S] cluster at the active site, which serves as the source of electrons in the reaction (Figure 1 ) [21, 22] . Cluster insertion is facilitated by the cytosolic iron-sulphur protein assembly (CIA) pathway, which comprises two distinct branches of targeting complexes [23] . Despite viperin's interaction with both branches of CIA targeting complexes, only one has been shown to confer [4Fe-4S] insertion ( Figure 1 ) [24] . ddhCTP has been shown to act as a chain terminator for viral RNA-dependent RNA polymerases (RdRp) from multiple Flavivirus members [20] , and this offers an explanation for viperin's ability to broadly limit this viral genus (reviewed in [7, 20] ). However, ddhCTP is unable to inhibit the polymerase activities of the Picornaviridae members human rhinovirus (HRV) C and poliovirus, despite viperin's previously identified antiviral capacity against HRV [25] ; which highlights the possibility that this highly evolutionarily conserved antiviral host protein, may still be involved in other as yet unidentified antiviral mechanisms.
Viperin is one of a small group of ISGs that are capable of acting as both direct antiviral effectors and indirectly as enhancers of innate immune signalling, to inhibit viral infection (reviewed in [26] ). Viperin can enhance the activation of key signalling molecules of both the TLR7 (ssRNA sensing) and TLR9 pathways (CpG DNA sensing), and is able to directly bind IRAK1 and TRAF6, to enhance the activation of IRAK1, via augmenting the molecule's K63-linked polyubiquitination [27] . This in turn results in a heightened production of interferon, and an enhanced antiviral response. Multiple viruses have PAMPs that activate these pathways, including IAV and VSV [28, 29] , which are known to be limited by viperin (reviewed in [7] ), and this mechanism may help explain some of the broader antiviral activities of viperin.
Here we show for the first time that viperin is also able to directly interact with the signalling adaptor molecule, stimulator of IFN genes (STING), and enhance production of antiviral cytokines following activation of dsDNA signalling pathways, and that this relies not only on its radical SAM enzymatic activity, but also its interaction with the iron-sulfur assembly component 2A (CIA2A). Viperin's ability to augment both dsDNA signalling, as well as TLR7 and 9 signalling, offers further explanation for this host protein's ability to limit such a broad range of viral families.
Results

Viperin enhances the STING-dependent type-I IFN response to dsDNA downstream of ligand detection
To investigate whether viperin plays a role in the enhancement of the IFN response to dsDNA we initially utilised in vitro cell culture-based luciferase assays. Ectopic expression of viperin in both HeLa and Huh-7 cells was observed to enhance the activity of the type-I IFNβ promoter in dual luciferase reporter assays following stimulation of the DNA viral mimic, poly dA:dT by approximately 2.5-fold and 2-fold respectively (Figure 2Ai & ii). These results were confirmed with the use of our previously developed primary viperin -/-MEFs [24] as well as a polyclonal Huh 7 cell line stably expressing shRNA targeting viperin mRNA [11] . As can be seen in Figure 2B , primary viperin -/-MEFs displayed an approximate 4-fold reduction in their expression of IFN-β mRNA relative to wild-type MEFs, and the activity of the IFN-β promoter was significantly reduced in the shViperin cells compared to the shControl cell line following poly dA:dT stimulation ( Figure 2C ). Together this data demonstrates the ability of viperin to enhance the type-I IFN response to exogenous dsDNA stimulus in multiple cell lines.
The detection of exogenous dsDNA within the host cell relies on the activity of multiple DNA sensors, however upon recognition of their ligands these receptors predominantly converge on the adaptor molecule STING [30] . To identify whether viperin's enhancement of the type-I IFN response to dsDNA stimulation involves an interaction with the downstream adaptor molecule STING, Huh-7 cells were co-transfected to ectopically express both viperin and STING in the absence of poly dA:dT stimulation. Cells expressing STING alone, in the absence of viperin expression, displayed a 3-fold increase in IFN-β promoter activity compared to cells transfected with control vector only (control)( Figure 2D ), indicating that overexpression of this adaptor molecule is sufficient to auto-activate the pathway. Furthermore, in the absence of poly dA:dT stimulation, co-transfection of STING with viperin resulted in significantly higher IFN-β promoter activity compared to STING alone ( Figure   2D ), suggesting viperin's enhancement of type-I IFN following dsDNA signalling occurs downstream of exogenous DNA recognition. Furthermore, viperin's co-transfection with STING also significantly upregulated the production of the key antiviral interferon stimulated genes (ISGs) IFI6 and OAS compared to STING alone ( Figure 2E ), indicating that this positive augmentation of the type-I IFN pathway results in a functional upregulation of ISGs downstream of dsDNA ligand recognition.
Viperin co-localises with TBK1 and STING, via a direct interaction with STING
The successful activation of signalling events initiated by dsDNA PRRs relies on the activity of two major adaptor molecules, STING and TBK1 [31, 32] . The ER-resident protein STING assembles with TBK1 after dsDNA stimulation to facilitate the phosphorylation of IRF3, culminating in the induction of type-I IFN [33, 34] . As viperin has previously been shown to co-localise and interact with alternate signalling adaptor molecules to enhance the efficacy of the TLR7/9 innate immune signalling pathways [27] , we investigated viperin's ability to colocalise with STING and TBK1.
Utilising in situ proximity localisation assays (PLA) in HeLa cells in conjunction with ectopically expressed viperin, we observed the co-localisation of viperin with endogenous STING and to a lesser degree endogenous TBK1 irrespective of poly dA:dT stimulation ( Figure 3A ). This co-localisation observed between viperin and TBK1/STING appeared to be enhanced during poly dA:dT stimulation ( Figure 3A ). To confirm these observations, we utilised confocal microscopy, where similar co-localisation was observed between viperin and either TBK1 or STING, however considerable co-localisation was only observed between viperin and TBK1 or STING following dsDNA stimulation ( Figure 3B and C). As can be seen in Figure 3B , the cytoplasmic localisation of TBK1 appeared to converge with viperin on lipid droplets, 2 hrs following poly dA:dT stimulation. Similar to viperin's localisation with TBK1, viperin appears to co-localise with STING around the BODIPYstained lipid droplets following poly dA:dT stimulation ( Figure 3C , indicated by white arrow), however at this point there is also considerable co-localisation of viperin and STING at discrete puncta throughout the cytoplasm, which is a hallmark of STING activation on the golgi [35] .
To further investigate the ability of viperin to form a complex with either STING or TBK1, coimmunopreciptation assays were performed. Preliminary immunoblot analysis was unable to detect TBK1 with immunoprecipitated viperin (Supplementary Figure 1A) . To elucidate whether this was the result of potentially weaker or transient binding interactions between the two proteins, a DSS cross-linker was utilised. Despite the addition of the cross-linker, TBK1 failed to be co-immunoprecipitated with viperin ( Figure 3D ). However, STING was successfully detected following co-immunoprecipitation assays with viperin, irrespective of poly dA:dT stimulation ( Figure 3E ). Further analysis identified the central domain of viperin to be responsible for this binding to STING (Supplementary Figure 1B ). Together these findings highlight the strong interaction between viperin and STING, and imply the formation of a complex between these two proteins, while also indicating that the co-localisation between viperin and TBK1 does not involve direct binding.
Viperin enhances the polyubiquitination-dependent activation of TBK1
The adaptor molecules involved in innate immune signalling events are commonly regulated by post-translational modifications such as polyubiquitination [36] . The addition of both K27and K63-linked ubiquitin chains to STING has been shown to facilitate optimal trafficking of the protein, enabling efficient activation of downstream signalling adaptors [37, 38] . To delineate viperin's mechanism of enhanced IFN-β promoter activity in the presence of dsDNA, we first investigated STING activation in the presence of viperin. However, viperin expression was not found to impact either K27-or K63-linked polyubiquitination of STING in HEK293T cells ( Figure 4A and B) . Moreover, the presence of dimerised and phosphorylated forms of STING, which are associated with the protein's ligand binding affinity and recruitment of downstream adaptor molecules respectively [39, 40] , were unaffected by the co-expression of viperin in HEK293T cells ( Figure 4C ).
The activation of TBK1 is regulated through the conjugation of K63-linked ubiquitin chains to lysine residues 30 and 401 along the protein [41] . To determine the impact of viperin on this polyubiquitination event, ectopically expressed viperin was visualised in Huh-7 cells ( Figure   4D ), prior to the determination of the polyubiquitination status of TBK1 through immunoprecipitation coupled with immunoblot analysis. There was substantial K63-linked polyubiquitination of TBK1 observed in cells containing viperin following a 2 hr poly dA:dT stimulation ( Figure 4E ), in contrast to the control. Furthermore, in primary wild-type MEFs, K63-linked polyubiquitination of endogenous TBK1 was observed to be markedly increased following poly dA:dT stimulation, compared to viperin -/-MEFs ( Figure 4F ). Collectively this data demonstrates that viperin enhances the K63-linked polyubiquitination of TBK1.
Viperin interacts with STING to enhance the type-I IFN response to limit HBV
To investigate whether viperin's ability to enhance a type-I IFN response to dsDNA would functionally affect the outcome of a DNA viral infection, we utilised a well-characterised HBV in vitro model viral system [42] . Figure 5B ). Similarly, a significant reduction in HBsAg and HBeAg was also observed in supernatants derived from cells expressing both viperin and STING compared to those solely expressing STING or viperin when transfected with the genotype-D HBV for 96 hrs ( Figure 5C ). STING activation has previously been demonstrated to limit HBV replication [43, 44] , and collectively, these results demonstrate that a STING mediated innate response can be enhanced by viperin, to control HBV infection in vitro.
Viperin's N-terminus and [[4Fe-4S]] cofactor contribute to its enhancement of the type-I IFN response to dsDNA
Viperin relies on the action of specific functional domains to inhibit multiple families of viral pathogens [7] . Its characteristic localisation to the outer lipid droplet membrane ( Figure 6A) is essential for its ability to enhance the type-I IFN response via TLR7/9 activation of plasmacytoid dendritic cells in the mouse [27] . To determine the potential role of certain viperin domains in its ability to enhance type-I IFN following poly dA:dT stimulation we utilised in vitro luciferase assays in combination with a panel of viperin mutants. As can be seen in Figure 6B , the 5'Δ33 viperin mutant, which lacks the first 33 amino acids of the Nterminus, and hence loss of its amphipathic helix [14] , and the SAM1 viperin mutant in which the [4Fe-4S] cluster-binding cysteine residues of the protein's radical SAM Motif 1 are mutated to alanine [14] , both showed a significant decrease in IFN-β promoter activity compared to those expressing viperin-wildtype following poly dA:dT stimulation, and resembled that of the cells entirely lacking viperin (control). Conversely, the 3'Δ17 viperin mutant which lacks 17 amino acids from the protein's C-terminus [14] , significantly enhances viperin's ability to upregulate IFN-β promoter activity ( Figure 6B ). This would imply that viperin requires either its localisation to the lipid droplet or specific sequences within its Nterminus, in conjunction with its binding to the [4Fe-4S] cluster, to enhance the type-I IFN response to dsDNA. Additionally, the ability of the 3'Δ17 viperin mutant to maintain enhancement of the IFN-β promoter driven luciferase, indicates that viperin does not require its radical SAM activity to augment the interferon response following detection of dsDNA, as the truncated C-terminal amino acids are required for [4Fe-4S] loading, a requirement for its enzymatic function [45] .
To further investigate the requirement of viperin's N-terminus in its augmentation of the dsDNA signalling pathway, we utilised a chimeric viperin mutant (NS5A-TN50-Viperin). This mutant lacks 50 amino acids from viperin's N-terminus, including its lipid droplet-localising amphipathic helix, but is substituted with the alternate amphipathic helix of HCV NS5A [45, 46] . Despite retaining viperin's typical cellular localisation [45] , this mutant was unable to enhance the induction of the IFN-β promoter to the same degree as wild-type viperin (p<0.01) ( Figure 6C ) following poly dA:dT stimulation, suggesting that localization to the lipid droplets is not of itself, sufficient for viperin's enhancement of the type-I IFN response to dsDNA and there may be additional N-terminal sequences contributing to this activity.
Viperin's interaction with STING and TBK1 activates it towards the synthesis of ddhCTP and facilitates self-limiting degradation.
As a radical SAM enzyme, viperin couples the reductive cleavage of SAM to the dehydration of CTP producing 5'-dA and ddhCTP as products ( Figure 1 ) [20] . We have previously shown that viperin's interaction with IRAK1 and TRAF6 to enhance TLR7/9 signalling results in significant stimulation of the enzyme's catalytic activity. Interestingly, the interaction with IRAK1 and TRAF6 resulted in more rapid degradation of viperin, which would act to limit viperin's antiviral activity [20, 47] . Moreover, high levels of 5'-dA have been demonstrated to act as a general inhibitor of radical SAM enzymes [48] . Therefore, we assessed whether viperin's interaction with the signalling adaptor molecules STING and TBK1 would similarly stimulate viperin's catalytic activity and result in more rapid degradation of viperin.
The enzymatic activity of viperin was assayed in extracts prepared from HEK293T cells expressing either viperin and/or STING and TBK1, as described previously [47] .
Consistently, the overexpression of STING, and to a lesser degree TBK1, significantly increased the catalytic activity of viperin, as determined by the amount of 5'-dA formed in the assay, compared to viperin alone when normalized for viperin expression levels ( Figure 7A ).
Interestingly, through immunoblot analysis we also observed significant degradation of viperin in HEK293T cells overexpressing STING at 40 hrs post transfection, which was not observed at earlier time points ( Figure 7B ). Together these data demonstrate that viperin's interaction with the signalling adaptor molecules of the dsDNA signalling pathway, STING and TBK1, both enhance viperin's enzymatic activity and facilitate viperin's degradation.
STING and TBK1 thereby act as a negative feedback loop to limit viperin's enhancement of immune signalling.
Viperin co-localises with CIA2A to enhance the type-I IFN response to dsDNA
The N-terminal region of viperin is responsible for its binding to the cytosolic iron-sulphur protein assembly (CIA) component 2A (CIA2A) (Figure 1 ), a protein which is part of a pathway responsible for the targeting of Fe-S clusters to some proteins, but has been reported to not contribute to the insertion of the [[4Fe-4S]] cluster into viperin [24] . Therefore, given viperin's requirement for N-terminal sequences to positively augment the type-I IFN response to dsDNA detection, we investigated a potential role for CIA2A in this novel viperin function.
Confocal microscopy revealed a cytoplasmic and nucleoplasmic localisation of CIA2A, which did not show any notable co-localisation with BODIPY-stained lipid droplets ( Figure 8A ).
However, the expression of viperin redistributed the localisation of CIA2A to convene on the lipid droplets, where the two proteins co-localised ( Figure 8A ). To determine the role of CIA2A in viperin's enhancement of the IFN response to dsDNA we utilised CRISPR/Cas9 technology to generate CIA2A-deficiencies in HeLa cells. We verified loss of CIA2A in three independent polyclonal populations of HeLa cells, each containing a distinct gRNA (hereafter referred to as CIA2A KO #1, CIA2A KO #2 and CIA2A KO #3)( Figure 8B ). Interestingly, these cells all displayed defects in their ability to drive an IFN-β promoter generated lucferase response when challenged with polydA:dT ( Figure 8C ). Most notably, the viperinmediated enhancement of the IFN-β promoter activity was significantly reduced in all three of the CIA2A-deficient cell populations compared to wild-type HeLa cells ( Figure 8C ).
Conversely, the combined overexpression of CIA2A and viperin further enhanced the activity of the IFN-β promoter following polydA:dT stimulation by 3-fold compared to viperin alone ( Figure 8D ). These findings implicate viperin's N-terminal association with CIA2A as a significant contribution towards its ability to enhance the type-I IFN response to dsDNA.
Discussion
Viperin is a potent antiviral host protein, associated with the inhibition of a broad range of viral infections (reviewed in [7] ), however the scope of viperin's antiviral capacity makes it increasingly difficult to discern the protein's mechanism of viral inhibition. To date viperin has been shown to target multiple stages of viral lifecycles through interactions with many, often functionally unrelated, host and viral proteins (reviewed in [7] ). The recent discovery that viperin synthesizes the novel nucleotide, ddhCTP, offers an explanation for its ability to inhibit Flavivirus infection and unequivocally links the protein's enzymatic function in its antiviral activity [20] . However, this mechanism of viperin's antiviral activity fails to account for each instance of the protein's ability to limit diverse viral pathogens. Recent literature has suggested that viperin's ability to positively regulate innate immune responses may elucidate a unifying antiviral mechanism for this potent antiviral protein [26, 27] . Here we show for the first time that viperin is able to enhance the innate immune response to dsDNA viral mimics and to DNA viral infection independently of its radical SAM activity, but dependent on the cytosolic iron-sulfur assembly component 2A (CIA2A). This work adds to the limited knowledge of viperin's alternate innate immune regulatory capacity.
Viperin's enhancement of the cellular innate response to dsDNA shares mechanisms with its ability to positively augment signalling activation following ssRNA and CpG DNA detection in a host cell. Here we show that viperin interacts with the signalling adaptor proteins, STING and TBK1, which are central to the dsDNA signalling pathways, to enhance the activation of TBK1. In previous work viperin was shown to interact with the signalling adaptor protein IRAK1 which is central to the TLR7 & 9 signalling pathway [27] ; However, in this instance viperin was also demonstrated to interact with the E3 ligase TRAF6 which was responsible for the polyubiquitination of IRAK1. While it is evident viperin directly binds to the adaptor protein STING ( Figure 3E) , which is the upstream adaptor protein of TBK1, the E3 ligase responsible for ligating the K63-linked ubiquitin chains to TBK1 remains unknown.
Microscopy based analysis confirmed that viperin co-localises with the E3 ligase TRAF6 following dsDNA stimulation ( Supplementary Figure 2A and B) , in a similar manner to that seen following activation of TLR7 and TLR9 [21] . We were also able to show that this is the case for viperin and the E3 ligase TRAF3 following dsDNA stimulation ( Supplementary   Figure 2A and C) . Both TRAF3 and TRAF6 have been previously implicated in the STING-TBK1 signalling axis [32, 33] , however, further analysis is required to determine the functional relevance of this co-localisation to viperin's enhancement of TBK1 activation.
The ability of viperin to enhance the dsDNA signaling pathway presents a novel mechanism for the protein's antiviral capacity against DNA viruses. To investigate this in the absence of potential direct antiviral activity, we utilised a plasmid-based induction model of HBV Viperin's ability to generate ddhCTP to inhibit the replication of members of the Flavivirus genus via inhibition of polymerase function, relies on its enzymatic cleavage of SAM [20] ; however, ddhCTP was found to not inhibit the polymerases of members of the Picornaviridae family. Additionally, the ability of ddhCTP to inhibit the HCV RdRp was considerably lower than either of the Flaviviruses, DENV or WNV RdRps in an ex vivo assay [20] , and other more diverse viruses such as HIV [10] and BUNV [49] are also inhibited by the functions of viperin's enzymatic radical SAM domain in an as yet unspecified manner.
Moreover, previous studies have demonstrated that the deletion of viperin's N-terminus significantly abrogates its inhibition of not only HCV [14] , but also CHIKV [50] , and WNV [51] ; a domain absent in the recombinant Rattus norvegicus viperin utilised to generate ddhCTP [20] . This evidence is suggestive of a potentially alternate antiviral role to viperin's generation of ddhCTP but reliant on its radical SAM domain, to achieve the observed levels of viperin mediated inhibition of multiple viruses.
The radical SAM activity of viperin may contribute to its ability to enhance innate immune signalling and be regulated by the alternate [4Fe-4S] insertion mechanisms. Here we demonstrate viperin's requirement for the insertion of the [4Fe-4S] cluster, a cofactor necessary for viperin's enzymatic activity (Figure 1) , within its radical SAM domain to enhance the type-I IFN response to dsDNA ( Figure 6B ). The insertion alone of this [4Fe-4S] cluster has previously been shown to stabilise viperin [52] , and is primarily inserted by the cytosolic iron-sulphur protein assembly (CIA) targeting complex CIA1-CIA2B-MMS19, via binding to the C-terminal W361 residue of viperin ( Figure 1 ) [24] . We have shown that the deletion of viperin's C-terminus, and hence deletion of viperin's interaction with this CIA complex, significantly increased viperin's ability to enhance dsDNA signalling while mutation of viperin's M1 domain which completely abrogates viperin's [4Fe-4S] binding capacity conversely reduced viperin's enhancement of dsDNA signalling ( Figure 6B ). This suggests that viperin's [4Fe-4S] insertion is imperative to its ability to enhance dsDNA signalling, but that insertion of the [4Fe-4S] may not be solely the role of the CIA1-CIA2B-MMS19. Indeed the original findings describing viperin [4Fe-4S] insertion show a compensatory role of the alternate CIA targeting factor CIA2A to form a complex with CIA1 (CIA2A-CIA1) and contribute to viperin [4Fe-4S] insertion in cells lacking its alternate isoform CIA2B, albeit less efficiently than the CIA1-CIA2B-MMS19 complex [24] . As CIA2A binds to viperin' N-terminus ( Figure 1 ) [24] , it is possible this protein maintains viperin's [4Fe-4S] insertion in the Cterminally truncated viperin mutant which is unable to bind the CIA1-CIA2B-MMS19 complex ( Figure 6B ). However, the abrogation of viperin's interaction with CIA2A through deletion of its N-terminus reduces its ability to enhance dsDNA signalling, suggests this interaction with CIA2A confers more than [4Fe-4S] insertion.
The less efficient contribution of CIA2A to viperin's [4Fe-4S] insertion may lessen viperin's enzymatic generation of 5'-dA to extend viperin's enhancement of dsDNA signalling. Viperin generates 5'-dA as a by-product of its radical SAM enzymatic function through the utilisation of [4Fe-4S] clusters (Figure 1 ). High levels of 5'-dA have been demonstrated to act as a general inhibitor of radical SAM enzymes [48] . We have shown previously that when viperin and IRAK1/TRAF6 interact [47] , high levels of 5'-dA are produced, and similarly, here we demonstrate for the first time, that this also occurs during viperin's interaction with STING ( Figure 7A ). Concurrently, we also see viperin degradation when overexpressed with STING ( Figure 7B ), which is also the case when viperin is in the presence of overexpressed IRAK/TRAF6 [20, 47] . This would indicate the existence of a self-limiting negative feedback loop of viperin's enhancement of innate immune signalling, whereby viperin's enzymatic activity is promoted during its interaction with STING/IRAK1/TRAF6 until 5'-dA levels reach inhibitory concentrations and lead to the degradation of viperin protein. Moreover, as the CIA2A-CIA1 complex contributes to viperin [4Fe-4S] insertion less efficiently than the CIA1-CIA2B-MMS19 complex, presumably during CIA2A depletion, which reduces viperin's ability to enhance the type-I IFN response following dsDNA recognition ( Figure 8C ), CIA2B would have no competition for binding to CIA1, and would efficiently facilitate generation of the selflimiting factor 5'-dA. Conversely, CIA2A overexpression leads to further enhancement of this pathway ( Figure 8D ). In this context the abundance of CIA2A likely outcompetes endogenous CIA2B for complex formation with CIA1. As CIA2A less efficiently contributes to the insertion of [4Fe-4S] into viperin and hence formation of 5'-dA, the overrepresented CIA2A likely mitigates viperin's degradation and allows for prolonged enhancement of the dsDNA pathway. The dual engagement with these two distinct CIA isoforms appears to represent a novel regulatory mechanism of viperin's antiviral activity, although further research is required to determine to contextual significance of each interaction.
The evolution of viperin predicates the protein's role in innate immune regulation. Viperin is highly conserved, showing high amino acid identity across not only vertebrates including mammals, fish (reviewed in [7] ) and reptiles [53] , but also invertebrates such as oysters [54] .
A recent study of the type-I 'interferome' identified viperin as a core IFN-induced antiviral factor across numerous vertebrate species [55] , highlighting the protein's ancestral role in antiviral innate immunity. Interestingly, a separate study of transcriptional divergence of the innate immune response between species revealed the high conservation of genes encoding proteins involved in immune response regulation as opposed to those with more direct acting effects on viral invasion [56] . Together this data provides evidence for viperin's ancestral role as a regulator of the innate immune response to viral infection, and here we describe another instance of viperin's enhancement of innate immune signalling events, complementary to its role in positively regulating TLR7/9 signalling ( Figure 9 ) [27] . 
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Materials and Methods
Cells and culture conditions
All mammalian cell lines were maintained at 37 °C in a 5% CO 2 air atmosphere. Huh-7 human hepatoma cells, HeLa human epithelial cells, HEK293T human embryonic kidney cells, as well as primary murine embryonic fibroblast (MEF) cells were maintained in DMEM (Gibco) containing 10% (v/v) FCS. HepG2 human hepatoma cells were maintained in MEM (Gibco) containing 10% (v/v) FCS. The viperin -/-MEFs were generated and prepared as previously described [9] . The polyclonal Huh-7 cell line stably expressing shRNA targeting viperin mRNA was as previously described [14] . 
Real time PCR
Immunoblot analysis
Lysates were subjected to SDS-PAGE. Proteins were transferred to 0.2 µm nitrocellulose membranes (Bio-Strategy) and probed with indicated primary antibodies. The protein bands were visualized using a SuperSignal West Femto Maximum Sensitivity Substrate (Thermo-Fisher Scientific) for horseradish peroxidase (HRP) conjugated secondary antibodies. The probing with the monoclonal mouse anti-β-actin antibody (Sigma) was used as a loading control. Membranes were scanned using an Amersham 600 chemiluminescent imager.
Dual luciferase reporter assay
Luciferase experiments were performed essentially as previously described [57] . Cells were seeded at 4 x 10 4 per well in 24-well plates, 24 hrs prior to transient transfection using Viafect (Promega) with 250 ng of a specified target construct as well as 250 ng pIFN-β-Firefly luciferase in combination with 2.5 ng of the constitutively expressing Renilla luciferase plasmid, pRL-TK. Following a further 24 hrs, cells were stimulated with synthetic viral mimics for specified time periods. Cells were lysed with 1 x PLB (Promega) and the luciferase outputs were measured with a dual luciferase reporter assay system (Promega) on a CLARIOstar (BMG LABTECH) microplate reader. All conditions were performed in at least triplicate.
Viral infection and viral mimics
Transfection of HBV was performed as previously described [28] , in HepG2 cells using a recombinant 1.3-mer transient transfection model system for HBV genotypes A and D. Cells were seeded at 1 x 10 5 per well in 24-well plates, 24 hrs prior to transient transfection using Viafect (Promega) with a combined total of 500 ng per well of the specified HBV 1.3 mer plasmid as well as target and luciferase plasmids. Cell supernatants were harvested at specified time points for quantitative serology as previously described [42] , and cell lysates were harvested for dual luciferase reporter assays.
Herpes simplex virus type I (HSV-1) strain KOS was used to infect HeLa cells washed with phosphate-buffered saline (PBS) at the indicated multiplicity of infection (MOI) in DMEM without FCS. After 1 hr of incubation, the infection medium was removed and replaced with DMEM containing 2.5% (v/v) FCS.
The dsDNA viral mimic poly dA:dT (Invivogen) was transfected into cells using DMRIE-C reagent (Life Technologies) as per manufacturer's instructions at a concentration of 1 µg/ml.
Immunofluorescence microscopy
All immunofluorescence staining was performed as previously described [58] , and was visualised using either a Nikon Eclipse Ti-E fluorescence inverted microscope or a Ziess Confocal LSM 780 microscope, and images were captured using NIS Elements software or ZEN microscopy software respectively.
Proximity ligation assay
Cells were seeded at 7 x 10 4 per well in 12-well plates, 24 hrs prior to transient transfection using Viafect (Promega) with the specified viperin-flag constructs. Following a further 24 hrs, cells were trypsinised and seeded at 3 x 10 3 per well in a 96-well plate, allowed to recover and then stimulated with viral mimics. Cells were fixed with 4% (w/v) paraformaldehyde and the proximity ligation assay (PLA) was conducted using the Duolink® In Situ Kit (Merck) as per the manufacturer's instructions. Positive interactions were visualized using a Nikon Eclipse Ti-E fluorescence inverted microscope and images were captured using NIS Elements software.
Enzyme activity assay
HEK293T cells transfected with viperin, and/or STING and TBK1 were harvested from one 10 cm diameter tissue culture plate each, resuspended in 500 µl of anoxic Tris-buffered saline (50 mM Tris-Cl, pH 7.6, 150 mM NaCl) containing 1% Triton X-100, sonicated within an anaerobic glovebox (Coy Chamber), and centrifuged at 14,000 g for 10 min. Dithiothreitol (DTT; 5 mM) and dithionite (5 mM) were added to the cell lysate together with CTP (300 μ M). The assay mixture was incubated at room temperature for 30 min prior to starting the reaction by the addition of SAM (200 µM). The assay was incubated for 60 min at room temperature, after which the reaction was stopped by heating at 95 °C for 10 min. The solution was chilled to 4 °C, and the precipitated proteins were removed by centrifugation at 14,000 rpm for 25 min. The supernatant was then extracted with acetonitrile. The amount of 5'-dA in the samples was quantified by UPLC-tandem mass spectrometry, and the amount of viperin present in the lysate quantified by immunoblotting as described previously [47] .
Results reported represent the average of 3 biological replicates of the assay.
Generation of CIA2A knockout HeLa cell lines
The CIA2A-targeting lentivirus was packaged using lentiCRISPRv2 system. HeLas were seeded at 2 x 10 5 per well in a 6-well plate and were transduced the next day with the lentiviral particles expressing Cas9 and three independent CIA2A-specific guide RNAs (#1 5'-CAGCGTCCAGGAGAGCAGCC-3', #2 5'-GGACGCTGAGCAGAGTCCTG-3' and #3 5'-GGGCAGCTCCCGGCTCAGAG-3'). At 48 hr-post transduction, fresh media containing 0.5 μ g/ml puromycin was added to select for cells transduced with the CIA2A-targeting lentivirus and Cas9 expression. After culturing in puromycin-containing media for an additional 72 hours, the cells were expanded, and then analysed for CIA2A protein expression by immunoblot analysis with rabbit polyclonal anti-FAM96A(CIA2A) (Thermo-Fisher Scientific, REF#PA5-66628) antibody.
Plasmid constructs and transfections
All plasmid constructs were transiently transfected into the indicated cells using Viafect of the viperin with a flag tag at the N-terminus. The viperin mutant plasmids viperin-5'Δ33flag, viperin-3'Δ17-flag and Viperin-SAM1-flag, were created as previously described [14] .
Viperin-mCherry and mCherry plasmids were created as previously described [13] . The reporter plasmid IFN-β-Luc (IFN-Beta_pGL3) was a gift from Nicolas Manel (Addgene plasmid # 102597) [59] . pRL-TK (Promega) consists of a TK promoter which drives the constitutive expression of Renilla luciferase. The, pCMV-STING-3Xmyc and pCMV-TBK1myc plasmids were a gift from Russell Diefenbach (Westmead Millennium Institute, Sydney).
These are vectors expressing an N-terminally myc-tagged STING or TBK1 proteins in transfected mammalian cells and are expressed constitutively by a CMV promoter. TBK1-mCherry was within pLenti-V5-D-TOPO-mCherry backbone where a CMV promoter drives its constitutive expression. The NS5A-TN50-viperin (NS5A-viperin) plasmid, which replaces the amphipathic helix of viperin with that of HCV NS5A was created as previously described [46] . The pEF-CIA2A-myc-his plasmid was a kind gift from Anna Överby (Umeå University, Sweden), and expresses N-terminally myc/His tagged CIA2A under the control of the EF-1α promoter. The ubiquitin plasmids pRK5-Ubiqutin-K48-HA and pRK5-Ubiquitin-K63-HA (Addgene) are constructed with a pRK5-HA backbone where the HA tag is at the N-terminus of ubiquitin. Hepatitis B virus 1.3 mer plasmid constructs for both genotype A and D are as previously described [42] .
The Nucleofector transfection kit (Lonza) was used to transfect siRNA into cells, according to the manufacturer's guide. In brief, 1 x 10 6 of HeLa cells were transfected with 50 nM of siRNA universal control (Sigma Aldrich) or siRNA specific for viperin (SASI_Hs02_00362416; Sigma Aldrich) by a Nucleofector 2b Device (Lonza). Post 24 hr transfection, cells were used for infection or collected for immunoblot analysis. The sequence of the siRNA specific for viperin was 5'-AGA GCG GAA AGT GGA ACG AGA-3'.
Statistical analysis
Results are expressed as mean ± S.E.M. Student's t test was used for statistical analysis, with p < 0.05 considered to be significant. All statistical analysis was performed using Prism 8 (GraphPad Software). There are two distinct branches of the CIA pathway, each comprising a unique targeting complex, responsible for inserting Fe-S clusters into Fe-S apo-proteins. Each branch is categorised by the involvement of either isoform of the CIA2 protein, CIA2A or CIA2B, within the targeting complex. Generally, CIA2A is responsible for the stabilisation and maturation of proteins involved in iron homeostasis, while CIA2B enables the maturation of most cytosolic and nuclear Fe-S proteins involved in generic housekeeping [23] . 1) Viperin binds CIA2A-CIA1 complex within the first 50 amino acid residues of its N-terminus, but is not responsible for the insertion of [4Fe-4S] into viperin [23, 24, 45] . 2) The alternate CIA targeting complex CIA1-CIA2B-MMS19 binds to the conserved tryptophan residue (W361aa) at viperin's C-terminus [45] , and is responsible for Here we show that viperin can enhance the dsDNA signalling pathway (Image left) in a similar manner to its enhancement of the TLR7/9 signalling pathways (Image right). In summary we have shown that upon detection of aberrant dsDNA either within the cytosol or nucleus, viperin is able to enhance the dsDNA signalling pathway; 1) viperin pre-emptively associates with CIA2A, 2) viperin interacts with STING and enhances the activation of TBK1 through K63 polyubiquitination, 3) this process enhances the type-I interferon response to dsDNA and limits DNA viral infection, 4) viperin's interaction with STING drives its enzymatic generation of 5'-dA, which results in viperin degradation. 
Figure legends
